Novo Biosciences Overview
- Founded
- 2012
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Seed
- Latest Deal Amount
- $4M
- Investors
- 5
Novo Biosciences General Information
Description
Developer of cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. The company's drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live a healthier life.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- One City Hall Plaza
- Ellsworth, ME 04605
- United States
+1 (207) 000-0000
Novo Biosciences Timeline
Novo Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 09-Jun-2020 | $4M | 00.000 | Completed | Pre-Clinical Trials | |
| 5. Grant | 07-Sep-2017 | 00.000 | 0000 | Completed | Pre-Clinical Trials | |
| 4. Grant | 01-Jan-2017 | 00.00 | 0000 | Completed | Pre-Clinical Trials | |
| 3. Accelerator/Incubator | 0000 | Completed | Pre-Clinical Trials | |||
| 2. Angel (individual) | 16-Jul-2015 | $75K | $75K | Completed | Pre-Clinical Trials | |
| 1. Grant | 17-Nov-2014 | $25K | Completed | Pre-Clinical Trials |
Novo Biosciences Executive Team (3)
Novo Biosciences Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kevin Strange Ph.D | Novo Biosciences | Co-Founder, Chief Executive Officer, Chairman & Board Member | 000 0000 |
| Voot Yin Ph.D | Novo Biosciences | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Novo Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNovo Biosciences Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Heart Blood and Lung Institute | Government | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Maine Technology Institute | Other | 000 0000 | 000000 0 | ||
| MDI Biological Laboratory | Accelerator/Incubator | 000 0000 | 000000 0 |